Jin Medical International Stock Today
| ZJYL Stock | 0.91 0.07 7.14% |
Performance0 of 100
| Odds Of DistressLess than 4
|
JIN MEDICAL is selling for 0.91 as of the 30th of November 2024. This is a 7.14 percent down since the beginning of the trading day. The stock's lowest day price was 0.81. JIN MEDICAL has only four percent chance of going through some form of financial distress over the next 2 years, but has generated negative returns over the last 90 days. Equity ratings for JIN MEDICAL INTERNATIONAL are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 28th of March 2023 | Category Healthcare | Classification Health Care |
JIN MEDICAL is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 156.55 M outstanding shares of which 932.37 K shares are at this time shorted by private and institutional investors with about 2.28 trading days to cover. More on JIN MEDICAL INTERNATIONAL
Moving against JIN Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
JIN Stock Highlights
| President Board | Erqi Wang | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
JIN MEDICAL can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand JIN MEDICAL's financial leverage. It provides some insight into what part of JIN MEDICAL's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
JIN MEDICAL INTERNATIONAL (ZJYL) is traded on NASDAQ Exchange in USA. It is located in No. 33 Lingxiang Road, Changzhou, China and employs 245 people. JIN MEDICAL is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 152.88 M. JIN MEDICAL INTERNATIONAL conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 156.55 M outstanding shares of which 932.37 K shares are at this time shorted by private and institutional investors with about 2.28 trading days to cover.
JIN MEDICAL generates positive cash flow from operations, but has no cash available
Check JIN MEDICAL Probability Of Bankruptcy
Ownership AllocationJIN MEDICAL INTERNATIONAL has a total of 156.55 Million outstanding shares. JIN MEDICAL retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.84 (percent) of JIN MEDICAL outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check JIN Ownership Details
JIN MEDICAL Historical Income Statement
JIN Stock Against Markets
Already Invested in JIN MEDICAL INTERNATIONAL?
The danger of trading JIN MEDICAL INTERNATIONAL is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of JIN MEDICAL is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than JIN MEDICAL. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile JIN MEDICAL INTERNATIONAL is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Earnings Share 0.02 | Revenue Per Share 0.129 | Quarterly Revenue Growth 0.03 | Return On Assets 0.0403 |
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.